|
1
|
Strimpakos AS, Cunningham D, Mikropoulos
C, Petkar I, Barbachano Y and Chau I: The impact of
carcinoembryonic antigen flare in patients with advanced colorectal
cancer receiving first-line chemotherapy. Ann Oncol. 21:1013–1019.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Riley CM and Ren TC: Simple method for the
determination of paeonol in human and rabbit plasma by
high-performance liquid chromatography using solid-phase extraction
and ultraviolet detection. J Chromatogr. 489:432–437. 1989.
View Article : Google Scholar
|
|
3
|
Chou TC: Anti-inflammatory and analgesic
effects of paeonol in carrageenan-evoked thermal hyperalgesia. Br J
Pharmacol. 139:1146–1152. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang H, Chang EJ, Lee Y, Kim JS, Kang SS
and Kim HH: A genome-wide microarray analysis reveals
anti-inflammatory target genes of paeonol in macrophages. Inflamm
Res. 57:189–198. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsieh CL, Cheng CY, Tsai TH, Lin IH, Liu
CH, Chiang SY, Lin JG, Lao CJ and Tang NY: Paeonol reduced cerebral
infarction involving the superoxide anion and microglia activation
in ischemia-reperfusion injured rats. J Ethnopharmacol.
106:208–215. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim SA, Lee HJ, Ahn KS, Lee HJ, Lee EO,
Ahn KS, Choi SH, Jung SJ, Kim JY, Baek N and Kim SH: Paeonol exerts
anti-angiogenic and anti-metastatic activities through
downmodulation of Akt activation and inactivation of matrix
metalloproteinases. Biol Pharm Bull. 32:1142–1147. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim SH, Kim SA, Park MK, Kim SH, Park YD,
Na HJ, Kim HM, Shin MK and Ahn KS: Paeonol inhibits anaphylactic
reaction by regulating histamine and TNF-alpha. Int
Immunopharmacol. 4:279–287. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun YC, Shen YX and Sun GP: Advances in
the studies of major pharmacological activity of paeonol. Zhong
Cheng Yao Zazhi. 26:579–582. 2004.(In Chinese).
|
|
9
|
Chen B, Ning M and Yang G: Effect of
paeonol on antioxidant and immune regulatory activity in
hepatocellular carcinoma rats. Molecules. 17:4672–4683. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li N, Fan LL, Sun GP, Wan XA, Wang ZG, Wu
Q and Wang H: Paeonol inhibits tumor growth in gastric cancer in
vitro and in vivo. World J Gastroenterol. 16:4483–4490. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee HJ, Kim SA, Lee HJ, Jeong SJ, Han I,
Jung JH, Lee EO, Zhu S, Chen CY and Kim SH: Paeonol oxime inhibits
bFGF-induced angiogenesis and reduces VEGF levels in fibrosarcoma
cells. PLoS One. 5:e123582010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wan XA, Sun GP, Wang H, Xu SP, Wang ZG and
Liu SH: Synergistic effect of paeonol and cisplatin on oesophageal
cancer cell lines. Dig Liver Dis. 40:531–539. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xing G, Zhang Z, Liu J, Hu H and Suqiura
N: Antitumor effect of extracts from moutan cortex on DLD-1 human
colon cancer cells in vitro. Mol Med Rep. 3:57–61. 2010.PubMed/NCBI
|
|
14
|
Ye JM, Deng T and Zhang JB: Influence of
paeonol on expression of COX-2 and p27 in HT-29 cells. World J
Gastroenterol. 15:4410–4414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
LaCasse EC, Mahoney DJ, Cheung HH,
Plenchette S, Baird S and Korneluk RG: IAP-targeted therapies for
cancer. Oncogene. 27:6252–6275. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang S: The promise of cancer therapeutics
targeting the TNF-related apoptosis-inducing ligand and TRAIL
receptor pathway. Oncogene. 27:6207–6215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang WS, Wang JP, Wang T, Fang JY, Lan P
and Ma JP: ShRNA-mediated gene silencing of beta-catenin inhibits
growth of human colon cancer cells. World J Gastroenterol.
13:6581–6587. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kaufmann SH and Hengartner MO: Programmed
cell death: alive and well in the new millennium. Trends Cell Biol.
11:526–534. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Clapham DE: Intracellular calcium.
Replenishing the stores. Nature. 375:634–635. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bootman MD, Berridge MJ and Roderick HL:
Calcium signalling: more messengers, more channels, more
complexity. Curr Biol. 12:R563–R565. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kruman I, Guo Q and Mattson MP: Calcium
and reactive oxygen species mediate staurosporine-induced
mitochondrial dysfunction and apoptosis in PC12 cells. J Neurosci
Res. 51:293–308. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martikainen P, Kyprianou N, Tucker RW and
Isaacs JT: Programmed death of nonproliferating
androgen-independent prostatic cancer cells. Cancer Res.
51:4693–4700. 1991.PubMed/NCBI
|
|
23
|
Bangsow C, Rubins N, Glusman G, Bernstein
Y, Negreanu V, Goldenberg D, Lotem J, Ben-Asher E, Lancet D,
Levanon D and Groner Y: The RUNX3 gene - sequence, structure and
regulated expression. Gene. 279:221–232. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Subramaniam MM, Chan JY, Yeoh KG, Quek T,
Ito K and Salto-Tellez M: Molecular pathology of RUNX3 in human
carcinogenesis. Biochim Biophys Acta. 1796:315–331. 2009.PubMed/NCBI
|
|
25
|
Ito K, Lim AC, Salto-Tellez M, Motoda L,
Osato M, Chuang LS, Lee CW, Voon DC, Koo JK, Wang H, Fukamachi H
and Ito Y: RUNX3 attenuates beta-catenin/T cell factors in
intestinal tumorigenesis. Cancer Cell. 14:226–237. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Licchesi JD, Westra WH, Hooker CM, Machida
EO, Baylin SB and Herman JG: Epigenetic alteration of Wnt pathway
antagonists in progressive glandular neoplasia of the lung.
Carcinogenesis. 29:895–904. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee JM, Kwon HJ, Bae SC and Jung HS: Lung
tissue regeneration after induced injury in Runx3 KO mice. Cell
Tissue Res. 341:465–470. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee KS, Lee YS, Lee JM, Ito K, Cinghu S,
Kim JH, Jang JW, Li YH, Goh YM, Chi XZ, Wee H, Lee HW, Hosoya A,
Chung JH, Jang JJ, Kundu JK, Surh YJ, Kim WJ, Ito Y, Jung HS and
Bae SC: Runx3 is required for the differentiation of lung
epithelial cells and suppression of lung cancer. Oncogene.
29:3349–3361. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Subramaniam MM, Chan JY, Soong R, Ito K,
Ito Y, Yeoh KG, Salto-Tellez M and Putti TC: RUNX3 inactivation by
frequent promoter hypermethylation and protein mislocalization
constitute an early event in breast cancer progression. Breast
Cancer Res Treat. 113:113–121. 2009. View Article : Google Scholar
|
|
30
|
Ito K, Liu Q, Salto-Tellez M, Yano T, Tada
K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, Hiong KC, Peh BK,
Han HC, Ito T, Teh M, Yeoh KG and Ito Y: RUNX 3, a novel tumor
suppressor, is frequently inactivated in gastric cancer by protein
mislocalization. Cancer Res. 65:7743–7750. 2005.PubMed/NCBI
|
|
31
|
Li QL, Ito K, Sakakura C, Fukamachi H,
Inoue KI, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ,
Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe
T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima
T, Bae SC and Ito Y: Causal relationship between the loss of RUNX3
expression and gastric cancer. Cell. 109:113–124. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ahlquist T, Lind GE, Costa VL, Meling GI,
Vatn M, Hoff GS, Rognum TO, Skotheim RI, Thiis-Evensen E and Lothe
RA: Gene methylation profiles of normal mucosa and benign and
malignant colorectal tumors identify early onset markers. Mol
Cancer. 7:942008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Subramaniam MM, Chan JY, Soong R, Ito K,
Yeoh KG, Wong R, Guenther T, Will O, Chen CL, Kumarasinghe MP, Ito
Y and Salto-Tellez M: RUNX3 inactivation in colorectal polyps
arising through different pathways of colonic carcinogenesis. Am J
Gastroenterol. 104:426–436. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chi XZ, Yang JO, Lee KY, Ito K, Sakakura
C, Li QL, Kim HR, Cha EJ, Kaneda A, Ushijima T, Kim WJ, Ito Y and
Bae SC: RUNX3 suppresses gastric epithelial cell growth by inducing
p21WAF1/Cip1 expression in cooperation with transforming
growth factor β-activated SMAD. Mol Cell Biol. 25:8097–8107. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wei D, Gong W, Oh SC, Li Q, Kim WD, Wang
L, Le X, Yao J, Wu TT, Huang S and Xie K: Loss of RUNX3 expression
significantly affects the clinical outcome of gastric cancer
patients and its restoration causes drastic suppression of tumor
growth and metastasis. Cancer Res. 65:4809–4816. 2005. View Article : Google Scholar
|
|
36
|
Müller I, Lipp P and Thiel G:
Ca2+ signaling and gene transcription in
glucose-stimulated insulinoma cells. Cell Calcium. 52:137–151.
2012.
|
